 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $19.989,86 | (28/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $7.995,94 AF $11.993,92 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $14.991,24 |
|
|
|
|
| cr.x 30 g | $39.202,27 | (28/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $15.680,91 AF $23.521,36 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $33.274,02 |
|
|
|
|
| ung.x 15 g | $18.944,18 | (28/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $7.577,67 AF $11.366,51 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $13.945,56 |
|
|
|
|
| ung.x 30 g | $36.308,32 | (28/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $14.523,33 AF $21.784,99 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $30.380,07 |
|
|
|
|
| |
